作者: Andrew Voigt , Alaa Shalaby , Samir Saba
DOI: 10.1016/J.JACC.2006.05.016
关键词:
摘要: To the Editor: Clinical indications for cardiac rhythm management devices (CRMDs) have expanded dramatically. The impact of this expansion upon rates CRMD infection, a complication device therapy that often requires system explantation ([1][1]), has not been clearly defined. We hypothesized